<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03110900</url>
  </required_header>
  <id_info>
    <org_study_id>206292</org_study_id>
    <nct_id>NCT03110900</nct_id>
  </id_info>
  <brief_title>Inhaled Loxapine vs IM Haloperidol + Lorazepam for Agitation</brief_title>
  <acronym>loxapine</acronym>
  <official_title>A Randomized Double-blind Multicenter Double-dummy Non-inferiority Trial of Inhaled Loxapine and Intramuscular Haloperidol + Lorazepam for the Reduction of Agitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mount Sinai Hospital, Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine the noninferiority of inhaled loxapine
      compared to intramuscular haloperidol/lorazepam on agitation reduction at 120 minutes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to determine the noninferiority of inhaled loxapine
      compared to intramuscular haloperidol/lorazepam on agitation reduction at 120 minutes.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sponsor Withdrawal
  </why_stopped>
  <start_date type="Actual">September 30, 2017</start_date>
  <completion_date type="Actual">April 4, 2018</completion_date>
  <primary_completion_date type="Actual">April 4, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of agitation on PANSS-EC</measure>
    <time_frame>120 minutes</time_frame>
    <description>agitation reduction</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Agitation,Psychomotor</condition>
  <condition>Haloperidol Causing Adverse Effects in Therapeutic Use</condition>
  <condition>Lorazepam Causing Adverse Effects in Therapeutic Use</condition>
  <condition>Loxapine Causing Adverse Effects in Therapeutic Use</condition>
  <arm_group>
    <arm_group_label>haloperidol + lorazepam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IM haloperidol 5mg + IM lorazepam 2mg + placebo inhaler</description>
  </arm_group>
  <arm_group>
    <arm_group_label>loxapine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inhaled loxapine 10mg + IM normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Haloperidol + lorazepam</intervention_name>
    <description>Haloperidol + lorazepam + placebo</description>
    <arm_group_label>haloperidol + lorazepam</arm_group_label>
    <other_name>Haldol + Ativan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Loxapine</intervention_name>
    <description>loxapine + placebo</description>
    <arm_group_label>loxapine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Requires treatment for agitation in the judgment of a physician

          2. Patient either pre-consented, has surrogate consent, or able to consent (in cases of
             mild agitation).

          3. The patient is at least 18 years of age and less than 65 years of age.

          4. Patients with known or presumed schizophrenia or bipolar 1 disorder.

        Exclusion Criteria:

          1. Patients with acute respiratory signs/symptoms (eg, wheezing).

          2. Known diagnosis of COPD or asthma or taking meds for asthma or COPD.

          3. Female patients who are obviously pregnant or breast-feeding.

          4. Medically unstable patients.

          5. Patients or surrogates who object to being in the study (even if previously
             pre-consented).

          6. Physician objection to patient enrollment in the study.

          7. Prisoners or incarcerated.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael P Wilson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UAMS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2017</study_first_submitted>
  <study_first_submitted_qc>April 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Haloperidol</mesh_term>
    <mesh_term>Lorazepam</mesh_term>
    <mesh_term>Haloperidol decanoate</mesh_term>
    <mesh_term>Loxapine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>April 9, 2018</submitted>
    <returned>May 8, 2018</returned>
    <submitted>May 11, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

